SCHEMBL28487299

SCHEMBL28487299

O=CC1CCCN(c2nccc3c2[nH]c2ccccc23)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 5/20 0.44
LMNA P02545 4/20 0.44
HSD17B10 Q99714 3/20 0.44
MAPK1 P28482 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KDM4E B2RXH2 8/20 0.43
ALDH1A1 P00352 7/20 0.43
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 6/20 0.42
GLA P06280 6/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
NPC1 O15118 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RAB9A P51151 2/20 0.42
ATM Q13315 2/20 0.42
TDO2 P48775 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10613479 0.80 HSD17B10 (0.63) DYRK1ALMNAHSD17B10MAPK1SMN1; SMN2
SCHEMBL7646497 0.72 HTR2A (0.46)
SCHEMBL8513030 0.69 GRM1 (0.46) HSD17B10KDM4EALDH1A1HPGDHTT
SCHEMBL29958390 0.68 HTT (0.62) LMNAHSD17B10MAPK1TSHRHTT
SCHEMBL2557692 0.68 KMT2A (0.46) KDM4EALDH1A1MEN1KMT2ANPC1
SCHEMBL3621970 0.65 GLA (0.66) LMNAHSD17B10MAPK1SMN1; SMN2KDM4E
SCHEMBL5806746 0.64 PDE3A (0.47) DYRK1A
SCHEMBL4687065 0.64 CHKA (0.52) MAPK1SMN1; SMN2KDM4EALDH1A1TSHR
Water SCHEMBL27633216 0.64 GLA (0.64) LMNAHSD17B10MAPK1SMN1; SMN2KDM4E
SCHEMBL7496088 0.64 TDO2 (0.53) HSD17B10MAPK1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112010939-B RGD sequence peptide modified hexacyclic piperazinedione, preparation, anti-inflammatory activity and application thereof 首都医科大学 2022-08-05 CN disclosed
CN-112010935-B Acetyl RGD modified hexacyclic piperazinedione, preparation, anti-tumor activity and application thereof 首都医科大学 2022-08-05 CN disclosed
CN-112010929-B RGD sequence peptide modified hexacyclic piperazinedione, preparation, transfer-resistant activity and application thereof 首都医科大学 2022-08-05 CN disclosed
CN-111978372-B RGD sequence peptide modified hexacyclic piperazinedione, preparation, antitumor activity and application thereof 首都医科大学 2022-08-02 CN disclosed
CN-112010938-B Acetyl RGD modified hexacyclic piperazinedione, preparation, anti-inflammatory activity and application thereof 首都医科大学 2022-08-02 CN disclosed
CN-112010934-B Acetyl RGD modified hexacyclic piperazinedione, preparation, transfer-resistant activity and application thereof 首都医科大学 2022-08-02 CN disclosed
CN-112010855-B Hexacyclic piperazinedione compounds, preparation, biological activity and application thereof 首都医科大学 2021-06-08 CN disclosed
CN-112010938-A Acetyl RGD modified hexacyclic piperazinedione, preparation, anti-inflammatory activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-112010929-A RGD sequence peptide modified hexacyclic piperazinedione, preparation, transfer-resistant activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-112010935-A Acetyl RGD modified hexacyclic piperazinedione, preparation, anti-tumor activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-112010934-A Acetyl RGD modified hexacyclic piperazinedione, preparation, transfer-resistant activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-112010855-A Hexacyclic piperazinedione compounds, preparation, biological activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-112010939-A RGD sequence peptide modified hexacyclic piperazinedione, preparation, anti-inflammatory activity and application thereof 首都医科大学 2020-12-01 CN disclosed
CN-111978372-A RGD sequence peptide modified hexacyclic piperazinedione, preparation, antitumor activity and application thereof 首都医科大学 2020-11-24 CN disclosed